Guidelines by Specialty
Guidelines by Organization

Oncology

Displaying 1–48 of 96 results

ASCO Guidelines Bundle

Last Updated: Dec 19, 2021
$ 662.95 Print Included Guidelines:
  • Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
  • Adjuvant Therapy for Stage III Colon Cancer
  • Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
  • Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer – Brain Metastases
  • Antiemetics
  • Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
  • Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
  • Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy
  • Axilla Management in Early-Stage Breast Cancer
  • Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
  • Biomarkers for Systemic Therapy in Metastatic Breast Cancer
  • Bone-Modifying Agents in Metastatic Breast Cancer
  • Bone-Modifying Agents in Multiple Myeloma
  • Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents
  • Cardiac Dysfunction - Prevention and Monitoring in Cancer Survivors
  • Cervical Cancer Prevention
  • Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma
  • Chemotherapy-Naïve Castration-Resistant Prostate Cancer
  • Chronic Pain in Survivors of Adult Cancers
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer Biomarkers
  • Colorectal Cancer Early Detection
  • Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
  • Diffuse Astrocytic and Oligodendroglial Tumors in Adults
  • Early-Stage Breast Cancer
  • Estrogen and Progesterone Receptor Testing in Breast Cancer
  • Exercise, Diet, and Weight Management During Cancer Treatment
  • Fertility Preservation
  • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
  • Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
  • HER2 Testing in Breast Cancer
  • Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy
  • HR-Positive, HER2-Negative Metastatic Breast Cancer
  • Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy
  • Immune-related Adverse Events — CAR T-Cell Therapy
  • Initial Management of Noncastrate Advance, Recurrent, or Metastatic Prostate Cancer
  • Integrative Medicine for Pain Management in Oncology
  • Invasive Cervical Cancer
  • Laryngeal Cancer
  • Late-Stage Colorectal Cancer
  • Lung Cancer Surveillance After Definitive Curative-Intent Therapy
  • Malignant Pleural Mesothelioma
  • Management of Cancer Cachexia
  • Management of Dyspnea in Advanced Cancer
  • Management of Hereditary Breast Cancer
  • Management of Male Breast Cancer
  • Management of Osteoporosis
  • Management of Salivary Gland Malignancy
  • Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
  • Medication-Related Osteonecrosis of the Jaw
  • Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy
  • Metastatic Pancreatic Cancer
  • Molecular Biomarkers in Localized Prostate Cancer
  • Multiple Myeloma
  • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer
  • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
  • Non-Small Cell Lung Cancer — Adjuvant Therapy for Completely Resected Stages I-IIIA
  • Optimum Imaging Strategies for Advanced Prostate Cancer
  • Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
  • Ovarian Masses and Treatment of Epithelial Ovarian Cancer
  • Palliative Care in the Global Setting
  • Pancreatic Cancer - Evaluating Susceptibility
  • PARP Inhibitors in the Management of Ovarian Cancer
  • Platelet Transfusion
  • Potentially Curable Pancreatic Adenocarcinoma
  • Prevention And Management Of Chemotherapy-Induced Peripheral Neuropathy In Survivors Of Adult Cancers
  • Salivary Gland Hypofunction and/or Xerostomia
  • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
  • Small Renal Masses
  • Somatic Genomic Testing for Metastatic or Advanced Cancer
  • Stage II Colon Cancer Adjuvant Therapy
  • Stage III Non-Small Cell Lung Cancer
  • Stage IV Non-Small Cell Lung Cancer without Driver Alterations
  • Systemic Therapy for Advanced Hepatocellular Carcinoma
  • Systemic Therapy for Melanoma
  • Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
  • Treatment for Brain Metastases
  • Treatment of Early-Stage Colorectal Cancer
  • Treatment of Locally Advanced Esophageal Carcinoma
  • Treatment of Metastatic Carcinoma and Myeloma of the Femur
  • Use of Endocrine Therapy for Breast Cancer Risk Reduction
  • Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
  • White Blood Cell Growth Factors
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Acromegaly

Last Updated: Jan 31, 2015
$ 9.95 Print

Medullary Thyroid Carcinoma

Last Updated: Feb 1, 2016
$ 11.95 Print
$ 13.95 Print
$ 9.95 Print
$ 13.95 Print
$ 9.95 Print

Anaplastic Thyroid Cancer

Last Updated: Mar 20, 2021
$ 11.95 Print
$ 9.95 Print

White Blood Cell Growth Factors

Last Updated: Jan 27, 2017
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Small Renal Masses

Last Updated: Mar 1, 2017
$ 7.95 Print

Early-Stage Breast Cancer

Last Updated: Jan 27, 2017
$ 7.95 Print
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Clear Cell Renal Cell Carcinoma

Last Updated: Jun 21, 2022
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Platelet Transfusion

Last Updated: Jan 16, 2018
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Palliative Care in the Global Setting

Last Updated: May 7, 2018
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print
$ 7.95 Print
$ 9.95 Print

Management of Osteoporosis

Last Updated: Oct 7, 2019
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Stage III Non-Small Cell Lung Cancer

Last Updated: Dec 22, 2021
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Multiple Myeloma

Last Updated: Apr 1, 2019
$ 9.95 Print

Malignant Pleural Mesothelioma

Last Updated: Jan 31, 2018
$ 9.95 Print
$ 9.95 Print
$ 9.95 Print

Metastatic Pancreatic Cancer

Last Updated: Oct 1, 2020
$ 9.95 Print

Systemic Therapy for Melanoma

Last Updated: Jun 3, 2022
$ 9.95 Print